Email from Alzheimer's Research and Prevention Foundation News from the Alzheimer's Research and Prevention Foundation June 2025 PRESIDENT'S MESSAGE A New Horizon in Alzheimer's Diagnosis  Dear John, I'm happy to hear about this new development in the diagnosis of Alzheimer's disease: The FDA has approved the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio, the first-ever blood test to aid in diagnosing Alzheimer's. Until now, confirming amyloid plaques – a hallmark of Alzheimer's – often required costly and invasive procedures like PET scans or spinal taps. This new blood test, proving simple and accessible, offers a less invasive alternative. It measures key proteins (pTau217 and β-Amyloid 1-42) to correlate with amyloid presence in the brain. As FDA Commissioner Martin A. Makary points out, "Alzheimer's disease impacts too many people, more than breast cancer and prostate cancer combined." With over 7 million Americans currently living with this disease, and projections rising significantly, innovations like this are critical. This test can lead to earlier and more accessible diagnosis, particularly for those in underserved areas or with limited access to specialized facilities. Earlier diagnosis can open doors to earlier intervention, potentially changing the course of the disease for many. This is good news, because people can then embark on our scientifically proven 4 Pillar Program to prevent Alzheimer’s - prevention is key. But remember, folks, although groundbreaking, this blood test is an aid in diagnosis, not a standalone definitive answer. It will be used in conjunction with other clinical assessments, and like all tests, it carries a possibility of false positives or negatives. Nevertheless, diagnostic tools becoming more patient-friendly and widely available is a win. It emphasizes the vital importance of ongoing research and our comprehensive approach to brain health. At ARPF, we remain dedicated to our 4 Pillars of Alzheimer's Prevention®, recognizing that while diagnosis is crucial, proactive lifestyle choices are paramount. This new diagnostic tool complements our prevention efforts, helping individuals understand their status earlier so they can embrace brain-healthy strategies with greater urgency and insight. Also, please recall that our Kirtan Kriya research reveals that we can clean the brain and decrease those plaques and tangles that are found in the brains of Alzheimer’s patients. It’s yet another reason to implement the 4 Pillars program. We are hopeful that this breakthrough will empower more people to take control of their brain health journey. If you’d like to learn more about our tested and immensely effective Brain Longevity formula, check out our on-demand programs.  Yours in Brain Health, Dharma Singh Khalsa, M.D. President / Medical Director LEARN MORE EDUCATIONAL OUTREACH ARPF Scientific Advisory Council Member, Dr. MaGloria Borras Boneu, Presents at European Congress Dr. MaGloria Borras Boneu, MD (pictured right) presented a research paper from ARPF's Pink BrainTM Project at the 15th European Congress on Menopause and Andropause in Valencia, Spain. The Pink Brain Project was a randomized study, conducted at UCLA under the direction of Helen Lavretsky, MD. It involved women over 60 with mild cardiovascular risk factors, obesity or memory complaints. Half were in the memory training program and half in a weekly group Kundalini Yoga class and daily Kirtan Kriya meditation practice for 12 weeks at home. Dr. Borras Boneu presented this research in the Menopause and Climacteric category, which included 106 topics in total. She chose the Complementary Medicine subtopic. Interestingly, this was the sole poster focusing on yoga and meditation across the entire congress, even within the broader lifestyle section. It can be surmised that even with the proven benefits of Kirtan Kriya, the research world has yet to catch up on the huge importance of lifestyle intervention techniques. Read more. Support Our Research DONOR SPOTLIGHT Samora Suber, AMFT, E-RYT 500, BLS ARPF would like to thank Samora Suber, AMFT, E-RYT 500, BLS for being part of our Brain Longevity community and an avid supporter of our research. "ARPF has given people the power to fight against Alzheimer’s disease and related illnesses. The research is extensive, the programs are informative, and the community is supportive. I will always support their work,” she said. Through dedication and outreach, individuals like Samora are not only enhancing their own lives but are actively contributing to ARPF’s mission to empower healthy aging and combat cognitive decline worldwide. We are so thankful to have her in our community and as an advocate for our research and programs. Read More. EDUCATIONAL OUTREACH Elder Abuse Webinar Recap We had an eye-opening webinar about Elder Abuse presented by the Manhattan District Attorney’s Office Elder Abuse Unit. We are so grateful to be advocates for seniors. Here's what participants said: "Absolutely critical information for keeping our elders and ourselves prepared and safe." "So useful! It can be hard for caregivers to deal with loved ones with dementia - but we help them from becoming victims of others." "I appreciated the presentation, thanks to the informative slides and examples given to underscore certain points. The dumpster-diving to steal sensitive information was new info to me. Thank you!" A huge Thank You to our speakers, Jeanine Launay, Esq. and Vimi Bhatia, Esq. for carrying out this important work. PRODUCT SPOTLIGHT The Pink BrainTM Project White Paper “Tremendous thanks for The Pink Brain Project White Paper. This inviting publication is a welcome tool to advance understanding in my local target market.” - Jo A., Brain Longevity Specialist DOWNLOAD Research News: ARPF research was cited in a new paper published in the scientific journal Therapeutic Advances in Ophthalmology. Here is the article quoted: Meditation and Music Improve Memory and Cognitive Function in Adults with Subjective Cognitive Decline: A Pilot Randomized Controlled Trial FOLLOW US Discover all the exciting activities ARPF has in store by visiting us on the web at: alzheimersprevention.org   Donate Now In Memory/ In Honor Donors May 2025 Thank you for giving ARPF the opportunity to honor your loved ones and your special occasions. Donor list from May. If you would like to leave a legacy for your loved one through supporting ARPF research and initiatives, please visit our page. We are so thankful to those who wish to include ARPF during such a sensitive time. We will continue to make strides in Alzheimer’s prevention in memory of all those who have been afflicted by dementia. We are forever grateful. WORKPLACE CAMPAIGNS ARPF is a proud participant in all workplace campaigns; these are only a few of the better-known ones: American Express Mayo Clinic Microsoft Subaru Whole Foods Market Check with your employer to see if the Alzheimer's Research and Prevention Foundation is on their list. Many employers also offer a donation match! ARPF NOW ACCEPTS ALL THE FOLLOWING DONATIONS  Securities and Stocks IRA Charitable Rollover Donor Advised Funds Your vehicle: car, truck, boat, motorcycle Cryptocurrency Please contact ARPF’s CEO Kirti Khalsa at 1-888-908-5766 or [email protected]. LEAVE A LEGACY: Remember Us in Your Will If you would like to receive information on how you can leave a legacy to support the Alzheimer’s Research and Prevention Foundation’s critical research initiatives, or to support one of our many other programs, please contact ARPF’s Vice President Randy Brooks at 1-888-908-5766 or by email. ARPF LEGACY SOCIETY Gold Level Mrs. Ethel A. Hoff Dr. and Mrs. Dharma Singh Khalsa Ms. Barbara Joan Davis Gail B. Campbell Ms. Anita Poorman Robert S. Gamblin Silver Level Mr. and Mrs. Claude and Billye Boucaud Mr. Carl G. Crawford Union Congregational Church Bronze Level Mr. and Mrs. Randy Brooks Ms. Mary Gilbert Mr. Edward T. Haats Hansel Trust Mrs. Marjorie Olmstead Shaol and Evelyn Pozez Endowment Fund Lawrence M. Robbin Did you know you can donate your car? Please click here for more information. Officers and Board Members PRESIDENT/MEDICAL DIRECTOR - Dharma Singh Khalsa, M.D. VICE PRESIDENT - Chris Walling, PsyD, MBA, C-IAYT TREASURER - Bert Beatty, MHA SECRETARY - Kirti K. Khalsa MEMBERS - Fletcher Wilkins, BS - Diane Ventura-Goodyear, MBA Executive Staff PROGRAMS DIRECTOR - Chelsea Pyne OUTREACH COORDINATOR - Camille Osorio Follow Us! Discover all the exciting activities the ARPF has in store for you by visiting us on the web at alzheimersprevention.org, following us on Twitter, ‘Liking’ us on Facebook, following us on Instagram. ARPF is a Proud Member of: Medical and Scientific Advisory Council CHIEF SCIENCE OFFICER George Perry, Ph.D., Professor of Biology & Chemistry, Chief Scientist, Brain Health Consortium University of Texas at San Antonio, TX ASSISTANT SCIENCE OFFICER Kateřina Sheardová, M.D., Ph.D., Head of the Memory Center ICRC St. Anne´s University Hospital Brno, Czech Republic ----------------------------------------------------------------- Daniel Amen, M.D., Director of the Amen Clinics, Costa Mesa, CA Lisa Barnes, Ph.D., Alla V. and Solomon Jesmer Professor Rush Alzheimer's Disease Center, Chicago, IL Ma Gloria Borras-Boneu, M.D., GRD Health Institute - Barcelona, Spain Hiroko Dodge, Ph.D., Kevreson Research Professor of Neurology University of Michigan, Ann Arbor, Oregon Health & Science University Nancy Emerson Lombardo, Ph.D., Adjunct Research Assistant Professor of Neurology Boston University, School of Medicine, Alzheimer’s Disease Center, Boston, MA Elissa Epel, Ph.D., Professor of Psychiatry, University of California, San Francisco, CA Fayron Epps, Ph.D., RN, Principal Investigator of the Faith Village Research Lab, Atlanta, GA Annie Fenn, M.D., Women’s health specialist & Founder of Brain Health Kitchen, Jackson Hole, WY Karen E. Innes, MSPH, Ph.D., Professor of Epidemiology, Western Virginia University School of Public Health, Morgantown, WV Richard S. Isaacson, M.D., Director, Alzheimer's Prevention Program, Florida Atlantic University Boca Raton, FL Tejinder Kaur Khalsa, M.D., M.S., FRCP, Consultant for WHO, Rochester, MN Miia Kivipelto, M.D., Ph.D., Aging Research Center and Alzheimer’s Disease Research Center, Karolinska Institute - Stockholm, Sweden Karen Koffler, M.D., Medical Director of the Osher Center for Integrative Medicine at University of Miami, FL Helen Lavretsky, M.D., M.S., Professor, Department of Psychiatry, UCLA Semel Institute and Resnick Neuropsychiatric Hospital- Los Angeles, CA Lisa Mosconi, Ph.D., Director, Alzheimer’s Prevention Clinic Weill Cornell Medical College, New York, NY Andrew B. Newberg, M.D., Director, Marcus Institute of Integrative Health –Myrna Brind Center Jefferson University Hospital, Philadelphia, PA Arti Prasad, M.D., FACP, Chief of Medicine, Hennepin Medical Ctr Professor/Vice Chair of Medicine, University of Minnesota Minneapolis, MN Michelle Sierpina, Ph.D., Founding Director, UTMB Osher Institute for Lifelong Learning University of Texas Medical Branch Galveston, TX Leonard A. Wisneski, MD, FACP, Clinical Professor of Medicine at George Washington University Medical Center, Washington, DC DONATE       Alzheimer's Research and Prevention Foundation | PO Box 30783 | Tucson, AZ 85751-0783 US Unsubscribe | Update Profile | Constant Contact Data Notice